1. Home
  2. NEXR vs CDT Comparison

NEXR vs CDT Comparison

Compare NEXR & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexera Technologies Ltd Ordinary Shares

NEXR

Nexera Technologies Ltd Ordinary Shares

N/A

Current Price

$1.04

Market Cap

953.3K

ML Signal

N/A

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$0.83

Market Cap

1.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXR
CDT
Founded
2021
2019
Country
Israel
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
953.3K
1.1M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
NEXR
CDT
Price
$1.04
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
247.5K
★ 3.3M
Earning Date
08-14-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.07
52 Week High
$5.28
$11.00

Technical Indicators

Market Signals
Indicator
NEXR
CDT
Relative Strength Index (RSI) 33.54 47.37
Support Level $0.23 $0.52
Resistance Level $1.95 $1.20
Average True Range (ATR) 0.16 0.12
MACD -0.05 0.06
Stochastic Oscillator 8.56 22.15

Price Performance

Historical Comparison
NEXR
CDT

About NEXR Nexera Technologies Ltd Ordinary Shares

Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Share on Social Networks: